/Companies

Wellumio

9 known investors

Find your way into Wellumio

Each arrow is one introduction. Sign up to fill in the first one.

685 people can intro you to Gyan

Ask Mitali Purohit to introduce you to Gyan Barik

You →Mitali · together at Wellumio →Gyan

574 people can intro you to Harry

Ask Jamie Chen to introduce you to Harry Marfatia

You →Jamie · together at Wellumio →Harry

101 people can intro you to Shieak

Ask Sam Okafor to introduce you to Shieak Tzeng

You →Sam · together at Wellumio →Shieak

Sign up to find every way you can get introduced to Wellumio

  • Your email: who you already know at Wellumio, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Wellumio team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Wellumio develops axana®, a portable, energy-efficient MRI system based on its Pulsed Gradient Free Mapping (PGFM) technology, designed to detect acute stroke quickly in front-line care settings. The product targets stroke diagnostics and brain imaging workflows in medical and critical care environments.

Founders & leadership

STShieak Tzeng
Shieak TzengCo-founder & Co-CEOShieak Tzeng is co-founder and co-CEO of Wellumio, which develops a portable MRI system for acute stroke detection in point-of-care settings. He previously co-founded and led a bioinformatics startup, held senior research positions at the University of Otago including directing translational research and bioengineering centers, and completed a postdoctoral fellowship in computational physiology at Harvard Medical School; he holds a medical degree and PhD from Otago University.
SOSergei Obruchkov
Sergei ObruchkovCo-founder & Co-CEO
GBGyan Barik
Gyan BarikExecutive Director, Business Operations & AustraliaGyan Barik has held leadership roles including Co-Founder, CEO, Director, VP of Products, and Chief Commercial Officer across ASX-listed companies, healthcare organisations, and early-stage startups over more than twenty years. He has spent the past decade focused on medical devices and health technology, with expertise in commercial strategy, regulatory pathways (TGA and FDA), and scaling early-to-growth stage businesses.
ZRZiad Rouag
Ziad RouagGeneral Manager USA
HMHarry Marfatia
Harry MarfatiaHead of FinanceHe previously held senior finance and commercial roles in ASX-listed healthcare, technology, and supply-chain companies, with over 18 years of experience in business scaling and governance.
DE
David EriksonProgram Manager

Board

SM
Sia MoussaviBoard Chairman

Investors · 9

Also in the syndicate · 1

Nuance Connected Capitallead

Funding

SEC filings, press & company announcements

$9.8M disclosed across 1 of 3 rounds · 2026

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Wellumio do?
Wellumio develops axana®, a portable, energy-efficient MRI system based on its Pulsed Gradient Free Mapping (PGFM) technology, designed to detect acute stroke quickly in front-line care settings. The product targets stroke diagnostics and brain imaging workflows in medical and critical care environments.
Who founded Wellumio?
Wellumio was founded by Shieak Tzeng, Sergei Obruchkov.
Who are Wellumio's investors?
Wellumio's investors include Booster Innovation Fund, Cure Kids Ventures, Enterprise Angels, Nuance Capital, NZ Growth Capital Partners, Outset Ventures, Pacific Channel, Icehouse Ventures.
How much funding has Wellumio raised?
Wellumio has disclosed $9.8M raised across 1 of its 3 known rounds.